Mergers and Acquisitions (M&A): 10x Genomics (Nasdaq: TXG) to Acquire Scale Biosciences.
10x Genomics has announced the acquisition of Scale Biosciences. According to the company announcement 10x Genomics, Inc. (Nasdaq: TXG) is a life science technology company based in Pleasanton, California, recognized as a leader in single cell and spatial biology. The company develops integrated research solutions, including instruments, consumables, and software, to accelerate the mastery of biology and advance human health. These solutions enable academic and translational researchers, as well as biopharmaceutical companies, to understand biological systems with high resolution and scale. 10x Genomics is actively expanding its capabilities, as evidenced by its acquisition of Scale Biosciences, which aims to further enhance its Chromium platform and broaden access to single cell analysis globally.
To learn more about 10x Genomics, visit https://www.10xgenomics.com/
Company LinkedIn Page: https://www.linkedin.com/company/10xgenomics/
Company Contact:
10x Genomics
6230 Stoneridge Mall Road Pleasanton, CA 94588
925-401-7300
SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.
